LLY
Price
$780.67
Change
+$1.39 (+0.18%)
Updated
Jul 3 closing price
Capitalization
739.66B
32 days until earnings call
MRK
Price
$80.93
Change
-$1.46 (-1.77%)
Updated
Jul 3 closing price
Capitalization
331.75B
23 days until earnings call
Interact to see
Advertisement

LLY vs MRK

Header iconLLY vs MRK Comparison
Open Charts LLY vs MRKBanner chart's image
Eli Lilly & Co
Price$780.67
Change+$1.39 (+0.18%)
Volume$1.45M
Capitalization739.66B
Merck & Co
Price$80.93
Change-$1.46 (-1.77%)
Volume$7.73M
Capitalization331.75B
LLY vs MRK Comparison Chart in %
Loading...
LLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LLY vs. MRK commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LLY is a Hold and MRK is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (LLY: $780.67 vs. MRK: $80.93)
Brand notoriety: LLY and MRK are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: LLY: 36% vs. MRK: 51%
Market capitalization -- LLY: $739.66B vs. MRK: $331.75B
LLY [@Pharmaceuticals: Major] is valued at $739.66B. MRK’s [@Pharmaceuticals: Major] market capitalization is $331.75B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LLY’s FA Score shows that 2 FA rating(s) are green whileMRK’s FA Score has 2 green FA rating(s).

  • LLY’s FA Score: 2 green, 3 red.
  • MRK’s FA Score: 2 green, 3 red.
According to our system of comparison, both LLY and MRK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LLY’s TA Score shows that 5 TA indicator(s) are bullish while MRK’s TA Score has 6 bullish TA indicator(s).

  • LLY’s TA Score: 5 bullish, 5 bearish.
  • MRK’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, both LLY and MRK are a good buy in the short-term.

Price Growth

LLY (@Pharmaceuticals: Major) experienced а -1.82% price change this week, while MRK (@Pharmaceuticals: Major) price change was +2.66% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.13%. For the same industry, the average monthly price growth was +2.56%, and the average quarterly price growth was +9.33%.

Reported Earning Dates

LLY is expected to report earnings on Oct 30, 2025.

MRK is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+1.13% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LLY($740B) has a higher market cap than MRK($332B). MRK has higher P/E ratio than LLY: MRK (935.64) vs LLY (131.13). LLY YTD gains are higher at: 1.505 vs. MRK (-17.123). LLY has higher annual earnings (EBITDA): 8.57B vs. MRK (6.91B). MRK has more cash in the bank: 7.09B vs. LLY (2.93B). LLY has less debt than MRK: LLY (25.2B) vs MRK (35.1B). MRK has higher revenues than LLY: MRK (60.1B) vs LLY (34.1B).
LLYMRKLLY / MRK
Capitalization740B332B223%
EBITDA8.57B6.91B124%
Gain YTD1.505-17.123-9%
P/E Ratio131.13935.6414%
Revenue34.1B60.1B57%
Total Cash2.93B7.09B41%
Total Debt25.2B35.1B72%
FUNDAMENTALS RATINGS
LLY vs MRK: Fundamental Ratings
LLY
MRK
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
12
Undervalued
PROFIT vs RISK RATING
1..100
1077
SMR RATING
1..100
1524
PRICE GROWTH RATING
1..100
5662
P/E GROWTH RATING
1..100
96100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MRK's Valuation (12) in the Pharmaceuticals Major industry is significantly better than the same rating for LLY (82). This means that MRK’s stock grew significantly faster than LLY’s over the last 12 months.

LLY's Profit vs Risk Rating (10) in the Pharmaceuticals Major industry is significantly better than the same rating for MRK (77). This means that LLY’s stock grew significantly faster than MRK’s over the last 12 months.

LLY's SMR Rating (15) in the Pharmaceuticals Major industry is in the same range as MRK (24). This means that LLY’s stock grew similarly to MRK’s over the last 12 months.

LLY's Price Growth Rating (56) in the Pharmaceuticals Major industry is in the same range as MRK (62). This means that LLY’s stock grew similarly to MRK’s over the last 12 months.

LLY's P/E Growth Rating (96) in the Pharmaceuticals Major industry is in the same range as MRK (100). This means that LLY’s stock grew similarly to MRK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LLYMRK
RSI
ODDS (%)
Bearish Trend 4 days ago
56%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
71%
Bearish Trend 4 days ago
55%
Momentum
ODDS (%)
Bearish Trend 4 days ago
53%
Bullish Trend 4 days ago
49%
MACD
ODDS (%)
Bearish Trend 4 days ago
60%
Bullish Trend 4 days ago
49%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
55%
Bullish Trend 4 days ago
49%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 4 days ago
44%
Advances
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 5 days ago
48%
Declines
ODDS (%)
Bearish Trend 17 days ago
52%
Bearish Trend 11 days ago
50%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
39%
Bearish Trend 4 days ago
54%
Aroon
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
54%
View a ticker or compare two or three
Interact to see
Advertisement
LLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
JOET41.280.43
+1.05%
Virtus Terranova US Quality Momentum ETF
XLU81.840.61
+0.75%
The Utilities Select Sector SPDR® ETF
PBJA29.220.09
+0.32%
PGIM S&P 500 Buffer 20 ETF - Jan
MYI10.61N/A
N/A
Blackrock Muniyield Quality Fund III
PGMFF26.29N/A
N/A
Barclays Bank PLC

LLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, LLY has been loosely correlated with AZN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if LLY jumps, then AZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LLY
1D Price
Change %
LLY100%
+0.18%
AZN - LLY
45%
Loosely correlated
-2.36%
NVS - LLY
42%
Loosely correlated
-1.54%
OGN - LLY
39%
Loosely correlated
-1.87%
MRK - LLY
32%
Poorly correlated
-1.77%
PFE - LLY
32%
Poorly correlated
+0.24%
More